Moderna Inc(MRNA-Q)
NASDAQ

Today's Change
Real-Time Last Update Last Sale Cboe BZX Real-Time
Day Low54.51
Day High62.30
Open:56.21
Price movement based on the high, low and last over the given period.
Previous Close
52-Week High/Low
Volume
Average Volume
Price/Earnings (TTM)
Forward Annual Dividend & Yield
Market Capitalization, $M
5-Day Change
Realtime quote and/or trade prices are not sourced from all markets.
Select a category then submit the form to load news
Analysts Conflicted on These Healthcare Names: Moderna (MRNA) and Scienture Holdings (SCNX)
Analysts Offer Insights on Healthcare Companies: Madrigal Pharmaceuticals (MDGL), Moderna (MRNA) and Ionis Pharmaceuticals (IONS)
Moderna’s Maternal RSV Vaccine Study Reaches Completion: What Investors Should Watch
Moderna (MRNA) Gets a Hold from Bernstein
Analysts Offer Insights on Healthcare Companies: Moderna (MRNA), Ardent Health Partners, Inc. (ARDT) and Gilead Sciences (GILD)
Analysts Conflicted on These Healthcare Names: Moderna (MRNA) and Glaukos (GKOS)
Moderna’s CMV Vaccine Study Update: What mRNA‑1647 Progress Means for MRNA Investors
Barclays Sticks to Their Hold Rating for Moderna (MRNA)
Analysts Offer Insights on Healthcare Companies: Moderna (MRNA) and Mediwound (MDWD)
Analysts Offer Insights on Healthcare Companies: Labcorp Holdings (LH), Moderna (MRNA) and Celcuity (CELC)
Analysts Conflicted on These Healthcare Names: BeOne Medicines (ONC), Moderna (MRNA) and Danaher (DHR)

Profile

Moderna, Inc. is a clinical-stage pharmaceutical company, primarily focused on discovering and developing messenger RNA (mRNA) based therapies. The company's mRNA based COVID-19 vaccine, Spikevax (mRNA-1273), is approved for use in adults in the United States. The vaccine is also authorized for emergency use in several countries as COVID-19 vaccine. The company has also developed booster doses of its COVID-19 vaccine and is developing variant-specific booster candidates.